A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 31/407 (2006.01) A61K 41/00 (2006.01) A61P 27/12 (2006.01)
Patent
CA 2273010
Photodynamic therapy to prevent secondary cataracts is effected using photosensitizers such as green porphyrins as photoactive agents to destroy remnant lens epithelial cells.
On met en application une thérapie photodynamique au moyen de photosensibilisants, tels que des porphyrines vertes, en tant qu'agents photoactifs afin de détruire des cellules épithéliales résiduelles sur une lentille.
Bussanich Nick
Hariton Claude A. A.
Huber Gustav
Levy Julia G.
Mallek David R.
Ciba Vision Ag Hettlingen
Fetherstonhaugh & Co.
Novartis Ag
Qlt Inc.
Qlt Phototherapeutics Inc.
LandOfFree
Use of green porphyrins for the manufacture of a medicament... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of green porphyrins for the manufacture of a medicament..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of green porphyrins for the manufacture of a medicament... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1853500